| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.16 | 0.5 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.15 | 0.5 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.12 | 0.5 |